REUNION
Live / Applied — Third extension granted (statement of use) (as of 02 Jan 2026)
What this means for you
Not registered yet, but its 01 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98112206
- Mark type
- Stylized text
- Filed
- 01 Aug 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Kristin H. Altoff
Goods and services
- Class 005 — Pharmaceuticals: PRESCRIPTION MEDICINES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF DEPRESSION AND DEPRESSION SYMPTOMS; PRESCRIPTION MEDICINES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND PREVENTION OF PSYCHIATRIC CONDITIONS AND THEIR SYMPTOMS; PRESCRIPTION MEDICINES AND PHARMACEUTICAL PREPARATIONS THAT ENGAGE SEROTONERGIC RECEPTORS IN THE HUMAN BRAIN; PRESCRIPTION MEDICINES AND PHARMACEUTICAL PREPARATIONS THAT ACTIVATE OR SUPPRESS NEUROTRANSMITTERS IN HUMANS THAT REGULATE MOOD, APPETITE, SLEEP, LEARNING, AND MEMORY
Owner
- Reunion Neuroscience Inc., Philadelphia, PA, US
- Reunion Neuroscience Inc., Philadelphia, PA, US
Prosecution history
- 03 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jan 2026 — SOU EXTENSION 3 GRANTED
- 02 Jan 2026 — SOU EXTENSION 3 FILED
- 02 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2025 — SOU EXTENSION 2 GRANTED
- 02 Jul 2025 — SOU EXTENSION 2 FILED
- 02 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jan 2025 — SOU EXTENSION 1 GRANTED
- 02 Jan 2025 — SOU EXTENSION 1 FILED
- 02 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION